Table 3.
Relative risk of death in patients for different treatment intervals
| Variables | Unadjusted | Adjusted | |||
| HR | P value | HR | 95% CI | P value* | |
| Interval from cancer diagnosis to treatment | |||||
| ≤7 days (ref.) | |||||
| 8~14 days | 1.26 | <0.001 | 1.04 | 1.01 to 1.07 | 0.004 |
| 15~60 days | 1.30 | <0.001 | 1.06 | 1.04 to 1.09 | <0.001 |
| ≥61 days | 1.66 | <0.001 | 1.08 | 1.04 to 1.11 | <0.001 |
| Gender | |||||
| Female (ref.) | |||||
| Male | 1.54 | <0.001 | 1.50 | 1.47 to 1.53 | <0.001 |
| Age (years) | |||||
| ≤44 (ref.) | |||||
| 45~54 | 0.97 | 0.357 | 0.97 | 0.92 to 1.03 | 0.351 |
| 55~64 | 1.02 | 0.478 | 1.03 | 0.97 to 1.09 | 0.331 |
| 65~74 | 1.63 | <0.001 | 1.27 | 1.21 to 1.34 | <0.001 |
| ≥75 | 1.93 | <0.001 | 1.79 | 1.69 to 1.88 | <0.001 |
| Monthly salary | |||||
| Low income (ref.) | |||||
| ≤17 280 | 0.72 | <0.001 | 0.89 | 0.80 to 1.00 | 0.049 |
| 17 281~22 800 | 0.81 | <0.001 | 0.86 | 0.78 to 0.95 | 0.002 |
| 22 801~28 800 | 0.74 | <0.001 | 0.83 | 0.75 to 0.91 | <0.001 |
| 28 801~36 300 | 0.60 | <0.001 | 0.79 | 0.71 to 0.87 | <0.001 |
| 36 301~45 800 | 0.59 | <0.001 | 0.78 | 0.70 to 0.87 | <0.001 |
| ≥45 801 | 0.56 | <0.001 | 0.73 | 0.66 to 0.81 | <0.001 |
| Urbanisation level | |||||
| Level 1 (ref.) | |||||
| Level 2 | 1.07 | <0.001 | 0.99 | 0.96 to 1.02 | 0.523 |
| Level 3 | 1.20 | <0.001 | 1.04 | 1.00 to 1.07 | 0.036 |
| Level 4 | 1.21 | <0.001 | 1.01 | 0.98 to 1.05 | 0.596 |
| Level 5 | 1.33 | <0.001 | 1.01 | 0.95 to 1.08 | 0.671 |
| Level 6 | 1.39 | <0.001 | 1.09 | 1.04 to 1.15 | 0.001 |
| Level 7 | 1.25 | <0.001 | 1.02 | 0.96 to 1.07 | 0.570 |
| CCI score | |||||
| ≤3 (ref.) | |||||
| 4~6 | 1.35 | <0.001 | 1.18 | 1.14 to 1.21 | <0.001 |
| ≥7 | 1.80 | <0.001 | 1.28 | 1.25 to 1.31 | <0.001 |
| Other catastrophic illness | |||||
| No (ref.) | |||||
| Yes | 1.25 | <0.001 | 1.26 | 1.19 to 1.33 | <0.001 |
| Cancer stage | |||||
| Stage I (ref.) | |||||
| Stage II | 2.29 | <0.001 | 2.06 | 1.91 to 2.23 | <0.001 |
| Stage III | 4.48 | <0.001 | 3.94 | 3.75 to 4.13 | <0.001 |
| Stage IV | 6.51 | <0.001 | 5.89 | 5.62 to 6.17 | <0.001 |
| MDT care | |||||
| No (ref.) | |||||
| Yes | 0.95 | 0.001 | 0.91 | 0.88 to 0.94 | <0.001 |
| Hospital level | |||||
| Medical centres (ref.) | |||||
| Regional hospitals | 1.28 | <0.001 | 0.99 | 0.96 to 1.02 | 0.347 |
| District hospitals | 2.06 | <0.001 | 1.25 | 1.17 to 1.34 | <0.001 |
| Others | 1.17 | 0.137 | 0.90 | 0.73 to 1.10 | 0.286 |
| Hospital ownership | |||||
| Public (ref.) | |||||
| Private | 1.27 | <0.001 | 1.13 | 1.10 to 1.16 | <0.001 |
| Hospital services volume | |||||
| Low (ref.) | |||||
| Middle | 0.72 | <0.001 | 0.83 | 0.81 to 0.85 | <0.001 |
| High | 0.59 | <0.001 | 0.71 | 0.68 to 0.74 | <0.001 |
*Cox proportional hazards regression.
CCI, Charlson Comorbidity Index; MDT, multidisciplinary team.